{"abstract": "Merck and Schering-Plough said that they would pay $41.5 million to settle suits claiming they delayed study results on their cholesterol drug Vytorin because the data was unfavorable.", "web_url": "https://www.nytimes.com/2009/08/06/business/06drug.html", "snippet": "Merck and Schering-Plough said that they would pay $41.5 million to settle suits claiming they delayed study results on their cholesterol drug Vytorin because the data was unfavorable.", "lead_paragraph": "Merck and Schering-Plough agreed Wednesday to pay $41.5 million to settle class-action lawsuits that accused them of withholding unfavorable results of a clinical trial of the cholesterol drugs Vytorin and Zetia.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "Schering and Merck Are Settling Vytorin Suits", "kicker": null, "content_kicker": null, "print_headline": "Schering and Merck to Settle Cholesterol Drug Lawsuits", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Schering Plough Corp", "rank": 2, "major": "N"}, {"name": "subject", "value": "Vytorin (Drug)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Suits and Litigation", "rank": 4, "major": "N"}], "pub_date": "2009-08-05T14:32:52+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Gerry Shih", "person": [{"firstname": "Gerry", "middlename": null, "lastname": "Shih", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/b7d7da29-afed-50f2-afcc-99d42a46dd65", "word_count": 287, "uri": "nyt://article/b7d7da29-afed-50f2-afcc-99d42a46dd65"}